FIELD: medicine.
SUBSTANCE: peptide immunogen is characterized by the amino acid sequence CKGPIVLDGVIKTQPHAAEK (SEQ ID NO: 1), identical to the amino acid sequences of the active site of the EGFR receptor, and contains a covalently bound carrier protein. It contains bovine serum albumin (BSA), or cationized bovine serum albumin, or ovalbumin or hemocyanin as the carrier protein.
EFFECT: application of this invention allows preparation of an immunogen peptide used in a therapeutic vaccine for metastatic breast cancer treatment due to the high immunogenicity of the peptide, and for assurance of an immune response only to the protective epitopes of the target tumour markers that block the main pathways of tumour growth and metastasis.
2 cl, 1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE-IMMUNOGEN USED IN THERAPEUTIC VACCINE FOR TREATMENT OF METASTATIC BREAST CANCER OF CATS AND DOGS | 2015 |
|
RU2612015C2 |
| VACCINE COMPOSITION AGAINST COVID-19 | 2020 |
|
RU2743595C1 |
| PEPTIDE IMMUNOGENS AND A VACCINE COMPOSITION AGAINST CORONAVIRUS INFECTION COVID-19 USING PEPTIDE IMMUNOGENS | 2020 |
|
RU2738081C1 |
| PEPTIDE IMMUNOGENS AND VACCINE COMPOSITION AGAINST COVID-19 WITH THE USE OF PEPTIDE IMMUNOGENS | 2020 |
|
RU2743593C1 |
| PEPTIDE IMMUNOGENS USED AS COMPONENTS OF VACCINE COMPOSITION AGAINST COVID-19 | 2020 |
|
RU2743594C1 |
| IMMUNOGEN PEPTIDES AND "EPIVAKEBOL" VACCINE AGAINST EBOLA FEVER WITH APPLICATION OF INDICATED PEPTIDES | 2017 |
|
RU2635998C1 |
| NEW PEPTIDES AND THERAPETIC USE THEREOF | 2003 |
|
RU2326125C2 |
| VACCINE COMPOSITION FOR CONTROLLING INFESTATION WITH ECTOPARASITES | 2011 |
|
RU2585226C2 |
| IMMUNOGENIC PEPTIDE FRAGMENT OF ADAMTS-7 METALLOPROTEINASE AND ITS USE IN COUNTERACTING ATHEROSCLEROSIS AND RELATED DISEASES | 2020 |
|
RU2799526C1 |
| PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPY SCHEMES BASED ON VACCINES | 2013 |
|
RU2609651C2 |
